ArticleInflammopharmacology2025

Neuroinflammation and metabolic dysregulation as predictors of cognitive impairment, depression, and quality of life in type 2 diabetes mellitus patients on SGLT2 inhibitors and sulfonylureas.

Haya Majid et al.PubMed ↗Publisher ↗

No numbers read from the abstract.